IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q2 2024 Holdings

Filed 2024-08-15 | 13 holdings | $39.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$28.7M123,78572.6%
Biontech SE(BNTX)COM09075V102$10.6M132,29326.9%
Exelixis Inc(EXEL)COM30161Q104$37.7K1,677,3930.1%
United Therapeutics Corp(UTHR)COM91307C102$37.7K118,2080.1%
Taro Pharmaceutical IndusCOMM8737E108$28.0K650,0890.1%
Cardinal Health Inc(CAH)COM14149Y108$21.4K217,6560.1%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$16.2K1,251,3380.0%
Jazz Pharmaceuticals PLC(JAZZ)COMG50871105$11.6K109,0760.0%
Regeneron Pharmaceuticals(REGN)COM75886F107$8.3K7,8530.0%
Sanofi(SNY)COM80105N105$7.5K153,8320.0%
Alkermes PLC(ALKS)COMG01767105$6.2K257,5540.0%
Vanda Pharmaceuticals Inc(VNDA)COM921659108$3.7K662,1660.0%
Mural Oncology PLCCOMG63365103$23675,0570.0%